RxDoctor Payments Data

Patrick Sullivan, MD

Colon & Rectal Surgery · Atlanta, GANPI 1790969780

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $29,955 of the $41,065 with a category attached, or 72.9%. Merck accounts for 61.9% of it on its own, with 4 other manufacturers making up the rest.

$41,065in general payments, 2019–2025

Across 51 payments — averaging $805.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$25K
  • Intuitive Surgical$8K
  • Gilead$7K
  • Medtronic$127
  • Aroa Biosurgery Incorporated$57
$308,499in research payments, 2019–2025

Across 4 payments — averaging $77,125 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gilead$308K

What the payments were for

  • Consulting fees$29,95573%
  • Travel & lodging$3,0637%
  • Food & beverage$1,5474%
  • Education$6,50016%

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck19$25,414
Intuitive Surgical20$8,443
Gilead9$7,024
Medtronic1$127
Aroa Biosurgery Incorporated2$57

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$41,065 in reported general payments places this provider in the 85th percentile of 66 colon & rectal surgery providers in Georgia.

See all colon & rectal surgery providers in Georgia

Medicare billing

Part B allowed, 2024
$64,527
Medicare patients
180
Services billed
325

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban14$6,738
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl46$586
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl17$277
Ondansetron OdtOndansetron14$207
Tramadol Hcl38$63
Oxycodone Hcl18$63
Gabapentin12$45
Metronidazole11$20

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →